Mitsuya Morita

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Koji Abe, Masashi Aoki, Shoji Tsuji et al. · The Lancet Neurology · 2017 · 925 citations

Life Sciences, Neurology, Neuroscience +11

Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Masato Hasegawa, Tetsuaki Arai, Takashi Nonaka et al. · Annals of Neurology · 2008 · 779 citations · Full text

Life Sciences, Neurology, Neuroscience +17

The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis

Keiko Imamura, Yuishin Izumi, Akira Watanabe et al. · Science Translational Medicine · 2017 · 256 citations · Full text

Life Sciences, Neurology, Neuroscience +13

Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial

Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki et al. · The Lancet Neurology · 2010 · 188 citations

Medicine, Neurology, Pharmacotherapy +6

SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity

Mariusz Berdyński, Przemysław Miszta, Krzysztof Safranow et al. · Scientific Reports · 2022 · 170 citations · Full text

Life Sciences, Genetics, Neurology +17